3B Medical Files Suit Against ResMed for Alleged Antitrust Violations

Mar. 15, 2015, Lake Wales, FL — 3B Medical, Inc., an innovator and distributor of products used in the treatment of obstructive sleep apnea, has filed a legal action in the United States District Court for the Middle District of Florida alleging antitrust violations by ResMed. 3B Medical filed the action against ResMed alleging numerous antitrust…


Plaintiffs Seek Leave to File Second Amended Class Action Complaint in Employment Discrimination Case Against Indian IT company Infosys, Ltd.

Sept. 9, 2014, Milwaukee, WI – Kotchen & Low LLP moved for leave to file a Second Amended Class Action Complaint today in the U.S. District Court for the Eastern District of Wisconsin against Indian IT company Infosys, Ltd. and its subsidiary Infosys Public Services, Inc. Plaintiffs’ proposed Second Amended Class Action Complaint add additional…


K&L Helps Client Obtain Settlement in Patent Infringement Case Related to Dietary Supplement

July 30, 2014, Los Angeles, CA–Dietary supplement manufacturer Imagenetix, Inc. settled on confidential terms a patent infringement action that it had filed against its competitor Nikken, Inc. in the U.S. District Court for the Central District of California. Plaintiff Imagenetix had originally filed the case in 2011, alleging that Nikken infringed an Imagenetix patent related to…


Court Appoints Expert to Investigate Delta’s Discovery Practices Following Numerous Instances of Discovery Misconduct and False Certifications by Delta’s Counsel

Nov., 19, 2012, Atlanta, GA –The U.S. District Court for the Northern District of Georgia today ordered that Plaintiffs should retain an e-discovery expert to investigate Defendant Delta Air Lines’ discovery practices. As ordered by the Court, the expert will operate with Delta’s full cooperation and be given access to Delta’s facilities and personnel. Delta…


Government Entities Seek Approval of $82 Million AWP Prescription Drug Settlement

Boston, MA, Oct. 26, 2011 – Kotchen & Low LLP and its co-counsel have moved for preliminary approval of an $82 million settlement on behalf of a class of local government entities who were allegedly overcharged for prescription drugs by defendant McKesson Corporation, the country’s largest drug wholesaler. The class, certified on March 4, 2011,…


Daniel Kotchen Speaks at ABA Antitrust Conference

Washington, DC, March 30, 2011 — Daniel Kotchen participated today in a panel discussion at the American Bar Association, Antitrust Section’s annual Spring Meeting. Mr. Kotchen addressed the extent to which public signaling and invitations to collude may violate Section 1 of the Sherman Antitrust Act. Drawing on his recent litigation experiences, Mr. Kotchen explained…


Court Certifies Class of Government Entities Alleging Drug Overcharge

Boston, MA, March 4, 2011 – A federal court certified a class of cities, counties, and other government entities that allegedly overpaid for prescription drugs as a result of overcharges by McKesson Corporation, the largest drug wholesaler in the country. Plaintiffs allege that McKesson fraudulently inflated certain prescription drugs’ “Average Wholesale Price,” or “AWP” –…


Court Unseals Delta and AirTran Documents Related to Bag Fee Antitrust Litigation

Atlanta, GA, Aug. 20, 2010 – The Court overseeing In re Delta / AirTran Baggage Fee Antitrust Litigation, MDL 2089 (N.D. Ga.) unsealed a number of documents that had been produced by defendants in discovery in the lawsuit but had been designated as confidential by the defendants. Plaintiffs requested that the Court “unseal” certain documents…